Innovations
Commented by Stefan Feulner on August 26th, 2024 | 07:30 CEST
BYD, Altech Advanced Materials, Xiaomi - Battle for the gold of the energy transition
The energy transition is underway, and demand for electric vehicles is increasing, albeit more slowly than expected. Lithium has so far been fundamental to the electrification of transportation. To minimize dependence on China, which controls a large part of the mining and processing of the rare metal, the European Union is turning to Serbia, where considerable deposits for battery production lie dormant. However, in addition to lithium-ion batteries, there are alternatives "Made in Germany" that could set the future standard.
Read
Commented by Juliane Zielonka on August 2nd, 2024 | 06:30 CEST
Transformation in full swing: Altech, Volkswagen, and Bayer focus on new technologies and markets
Shortly after the grandiose Olympic opening ceremony, Paris showed us what it means to sit in the dark. One day after the opening ceremony, the inhabitants of the Seine were hit by a power outage. Speculation as to the cause ranges from a cyber attack to sabotage, similar to the recent arson attacks on the French rail network. But one thing is certain, it shows how fragile the power supply currently is. This is reason enough for Altech Advanced Materials to press ahead with the development of its stationary solid-state battery. A type of local battery power plant ensures a stable power supply, even with fluctuations in the grid due to wind and solar energy. The German company has another profitable development up its sleeve for the EV market. Volkswagen continues to focus on its electric vehicles and can look forward to increased sales in China. Nevertheless, the Wolfsburg-based company must make considerable savings to remain profitable. The results of the first half of the year provide deep insights. Additionally, for 27 million women in the US, ones battery can be figuratively "empty" at times. Fatigue, hot flashes, and nervousness are classic symptoms of menopause. 27 million is the market size of menopausal women that Bayer AG now aims to capture with a very special medication...
Read
Commented by Fabian Lorenz on June 12th, 2024 | 07:00 CEST
Shock at Plug Power! Thyssenkrupp Nucera and Altech Advanced Materials with up to 100% upside potential!
Alarm at Plug Power. After the price jump in May, the share has gone into reverse again and lost 10% of its value in just a few days. Financing worth billions for the struggling hydrogen pioneer is uncertain, bringing the Company's potential insolvency back into the focus of investors. German hydrogen hopeful Thyssenkrupp Nucera received positive analyst comments. Could the share perhaps even double in value? And what is Altech Advanced Materials doing? The shares of the German battery hopeful have bottomed out and may offer an entry opportunity. The market potential for Altech is huge.
Read
Commented by Stefan Feulner on June 3rd, 2024 | 07:00 CEST
Bloom Energy, Altech Advanced Materials, JinkoSolar - Renewables are booming again
The hype that began at the start of the decade was followed by disillusionment and drastic share price losses. Over the past three years, renewable energy companies such as Plug Power, Nel ASA & Co. have lost disproportionately to the broader market. For some months now, however, many share prices have been showing signs of bottoming out, which could herald the next upward movement. There is no question that hydrogen, photovoltaics, and wind energy technologies will be further expanded in the future.
Read
Commented by Juliane Zielonka on May 31st, 2024 | 07:00 CEST
Globex Mining, Samsung Electronics, BYD: Commodity rally and innovations from Asia
Increasing demand for generative AI, consumer electronics, and innovations in the automotive industry are significantly boosting demand for raw materials. These are golden times for explorers like Globex Mining. The Canadian company has such a broad-based commodities portfolio that it can be seen as a minerals land bank. For investors, this means reduced risk thanks to high diversification. Samsung Electronics is currently facing several challenges. Not only have they been overtaken by NVIDIA in chip production, but the workforce is also becoming restless. In South Korea, this would be the very first strike in the Company's history. Although the brand value is highly regarded globally, things seem to be quite off-kilter in Suwon. Innovations are produced in Asia. Car manufacturers such as BYD, Geely and Toyota are focusing on the next evolutionary stage in the development of electromobility. The EU, on the other hand, appears helpless and is trying to undermine competition with punitive tariffs. Will they succeed?
Read
Commented by Juliane Zielonka on May 30th, 2024 | 07:15 CEST
dynaCERT, Mercedes-Benz, Amazon - German Engineering: technological transformations in focus
Entrepreneurs like the founders of dynaCERT are creating solutions for a cleaner environment. With a hydrogen-based bridging technology specifically for diesel engines, emissions can be reduced while maintaining the same level of efficiency. Now, the management team is being strengthened by a top-notch individual from Germany with vast experience in growth strategies. Intelligent minds are urgently needed everywhere. At Mercedes-Benz, there seems to be too much reliance on the allure of the brand and a popular model. There is hardly any other explanation for the electrification of this off-road design icon. SAP and Amazon Web Services are entering a special German-American relationship. With their joint venture, they are bringing generative AI to companies, thereby increasing productivity. Three solutions from three companies, with a focus on German expertise.
Read
Commented by Armin Schulz on May 23rd, 2024 | 08:30 CEST
E.ON, MGI - Media and Games Invest, Bayer - Through transformation into a golden future
Sometimes, companies are forced to overhaul their business areas if they wish to survive. A transformation is then unavoidable, and hopefully, the companies emerge stronger in the end. However, there is also the possibility that management will recognize the signs of the times early on and adapt their business models. From traditional companies that are starting a second life through digital innovation to young start-ups that are becoming market leaders through strategic realignments, companies are constantly facing challenges. Their path to a golden future is characterized by visionary decisions, agile adjustments and an unwavering will to improve continuously. We have selected three candidates that are currently undergoing a transformation.
Read
Commented by Armin Schulz on May 6th, 2024 | 07:15 CEST
Bayer on the path out of crisis. With their oncology pipelines, are Defence Therapeutics and BioNTech also on the verge of a turnaround?
After several years of stumbling from one crisis to another, pharmaceutical and agrochemical giant Bayer is now showing signs of a recovery on the horizon. As Bayer navigates its long and rocky road out of the crisis, investors and industry experts are now turning their attention to two other exciting biotech companies: Defence Therapeutics and BioNTech. Both companies, which have caused a sensation in the past mainly due to their revolutionary approaches in cancer therapy, could follow in Bayer's footsteps with their promising oncology pipelines, moving from uncertainty to a bright future.
Read
Commented by André Will-Laudien on April 24th, 2024 | 07:00 CEST
Takeover rumors for biotech shares: BioNTech, Formycon, Cardiol Therapeutics and Novo Nordisk in focus
The biotech sector has significantly lagged behind the performance of artificial intelligence and high-tech this year. This is due to high inflation, which in turn has made an imminent interest rate cut unlikely. Nevertheless, Germany's economic conditions are deteriorating dramatically, particularly due to the ongoing geopolitical conflicts. It should, therefore, come as no surprise if the ECB announces an "emergency interest rate cut" in the summer. That would then be the starting signal for a major reshuffle out of the best performers of recent months and into the long-neglected biotech segment. We have selected a few interesting stocks.
Read
Commented by Fabian Lorenz on April 23rd, 2024 | 07:00 CEST
TAKEOVER FEVER for biotech shares! Evotec, Bayer, Vidac Pharma - Who will follow Morphosys?
There is takeover fever in the biotech sector. Genmab recently announced the acquisition of ProfoundBio, the US biotech company developing ovarian and endometrial cancer drugs, for USD 1.8 billion. With Morphosys, the takeover carousel is also turning in Germany. Who is the next candidate? Evotec is often mentioned. Due to unauthorized insider trading, the biotech company's shares have come under fire this year and offer an interesting entry opportunity. Vidac Pharma also impresses operationally. The Company's new approach has the potential to revolutionize cancer treatment. The study results of the past few months are very promising. Bayer shares surprised investors yesterday as one of the day's winners in the DAX. Is the Leverkusen-based company's stock about to take off?
Read